ORIC Pharmaceuticals, Inc.

ORIC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$10.60-4.25%

2026-08-03

Financials

Valuation Metrics

ORIC Pharmaceuticals, Inc.'s Market Cap is $1.10B. At end of 2025 it was $718M. Ranked #2452 of 3,112 in US market (top 79%), #997 of 1,445 on NASDAQ (top 69%), #187 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 70%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.10B	US#2,452/3,112 Sec#187/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-135M	US—/3,112 Sec—/269
Total Assets	$437M	US#2,794/3,112 Sec#173/269
Net Assets	$416M	US#2,388/3,112 Sec#128/269
Value
P/B	2.64x	US#1,528/3,112 Sec#76/269
FCF Yield	-10.15%	US—/3,112 Sec—/269
Profitability
ROE	-32.54%	US#2,635/3,112 Sec#134/269
ROA	-30.96%	US#2,878/3,112 Sec#164/269
Financial Health
Debt Ratio	5.10%	US#49/3,112 Sec#19/269
Total Debt	$3M	US#2,883/3,112 Sec#228/269
FCF	$-111M	US#2,609/3,112 Sec#158/269
Cash	$56M	US#2,526/3,112 Sec#217/269
Current Ratio	16.33x	US#152/3,112 Sec#47/269
Performance
1Y Return	4.74%	US#1,798/3,112 Sec#180/269
1M Return	-8.93%	US#2,538/3,112 Sec#155/269
From 52W High	-29.00%	US#2,130/3,112 Sec#159/269
1Y MDD	-48.09%	US#2,330/3,112 Sec#180/269
Trading
Volume	2,308,075 shares	US#785/3,112 Sec#71/269
Trading Value	$25M	US#1,846/3,112 Sec#131/269
Per Share
EPS	$-1.47	US—/3,112 Sec—/269
BPS	$4.38	US#2,282/3,112 Sec#141/269